Vaccine Shown 96 Percent Effective in UK Trial
Novavax, Inc.'s COVID-19 vaccine was 96 percent effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdo…
Novavax, Inc.'s COVID-19 vaccine was 96 percent effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdo…